Safety Should Always Be a Priority With Car T for Multiple Myeloma: Surbhi Sidana, MD, MBBS

Cilta-cel’s mechanism of action allows it to penetrate challenging areas of multiple myeloma, providing deep and durable responses even in high-risk patients, explains Surbhi Sidana, MD, MBBS, Stanford University. Still, safety trade-offs should always be a consideration, she adds.